GnRH Activates ERK1/2 Leading to the Induction of c-fos and LHß Protein Expression in LßT2 Cells
Fujun Liu,
Darrell A. Austin,
Pamela L. Mellon,
Jerrold M. Olefsky and
Nicholas J. G. Webster
Departments of Medicine (F.L., J.M.O., N.J.G.W.) and Reproductive Medicine (P.L.M.) and the University of California San Diego Cancer Center (P.L.M., N.J.G.W.), University of California, San Diego, California 92093; and the Medical Research Service (D.A.A., N.J.G.W.), San Diego Veterans Healthcare System, San Diego, California 92161
Address all correspondence and requests for reprints to: Nicholas Webster, Department of Medicine 0673, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093-0673. E-mail: nwebster{at}ucsd.edu.
 |
ABSTRACT
|
---|
GnRH acts on pituitary gonadotropes to stimulate the synthesis and release of LH and FSH. However, the signaling pathways downstream of the GnRH receptor that mediate these effects are not fully understood. In this paper, we demonstrate that GnRH activates ERK, c-Jun N-terminal kinase, and p38MAPK in the LßT2 gonadotrope cell line. Phosphorylation of both ERK and p38MAPK are stimulated rapidly, 30- to 50-fold in 5 min, but activation of c-Jun N-terminal kinase has slower kinetics, reaching only 10-fold after 30 min. Activation of ERK by GnRH is blocked by inhibition of MAPK kinase (MEK) and partially blocked by inhibition of PKC and calcium, but not PI3K or p38MAPK signaling. We demonstrate that phosphorylated ERK accumulates in the nucleus in a PKC-dependent manner. We also show that GnRH induces c-fos and LHß subunit protein expression in LßT2 cells via MEK. Experiments with EGTA or calcium channel antagonists indicated that calcium influx is important for the induction of both genes by GnRH. In conclusion, these results show that GnRH activates all three MAPK subfamilies in LßT2 cells and induces c-fos and LHß protein expression through calcium and MEK-dependent mechanisms. These results also demonstrate that the nuclear translocation of ERK by GnRH requires PKC signaling.
 |
INTRODUCTION
|
---|
GnRH IS A hypothalamic peptide critical for normal mammalian reproductive function. GnRH acts on anterior pituitary gonadotropes to stimulate both the synthesis and release of the pituitary gonadotropins, FSH and LH. These two hormones are members of the glycoprotein hormone family that is characterized by a shared
-subunit and a unique, hormone-defining, ß-subunit (1). Analysis of the regulation of gonadotropin subunit gene expression by GnRH in the pituitary has been hampered by the dearth of cell lines that show appropriate regulation. Much of the original work was performed on dispersed primary cultures of pituitary cells or on artificial systems created by the transfection of the GnRH receptor into heterologous cells (2). Although the primary cultures contain about 510% mature gonadotropes, they represent a heterogeneous population of cells and are difficult to manipulate in vitro. The heterologous cell systems do show some responses to GnRH, due to the transfected receptor, but do not express the gonadotropin genes. The development of immortalized pituitary cell lines by targeted expression of SV40 large T antigen driven by the common glycoprotein hormone
-subunit promoter has greatly furthered our understanding of GnRH signaling (3). In particular, the
T31 cells are committed to the gonadotrope lineage as they express both the
-subunit gene and the GnRH receptor gene, but are considered immature, because they do not express the LHß and FSHß genes (4, 5). These cells have made possible the study of
-subunit gene expression as well as the regulation of endogenous GnRH receptors both at the genomic and posttranslational level (6). They have also been useful for analyzing the complex intracellular signaling events that follow GnRH stimulation. However, it has not been possible to study LHß and FSHß regulation in these cells. More recently, other immortalized pituitary cell lines have been developed by utilizing the LHß promoter for targeted expression of SV40 T-antigen in transgenic mice. These cells, the LßT2 and LßT4 cells, express both LHß and FSHß genes (7, 8). Moreover, both genes are regulated by GnRH, as is secretion of LH protein, and the cells are, thus, representative of mature pituitary gonadotropes.
The GnRH receptor is a member of the seven-transmembrane, or serpentine, class of receptors that couple to heterotrimeric G proteins (GPCRs). Binding of GnRH to its receptor initiates many signaling cascades similar to other GPCRs. One pathway leads to the activation of the MAPK family (9, 10, 11, 12, 13). MAPK cascades comprise one of the major signaling systems through which cells transduce and integrate diverse intracellular signals. The three subfamilies of the MAPKs are the ERKs, the c-Jun N-terminal kinases (JNK)/stress- activated protein kinases, and the p38 MAPKs (14, 15, 16, 17). The ERKs are strongly activated by polypeptide growth factors and phorbol esters but are weakly activated by environmental stresses such as osmotic or heat shock, UV light, and inhibitors of protein synthesis. In contrast, JNK and p38 MAPKs are strongly activated by cytokines and adverse stimuli but are poorly activated by growth factors.
All MAPKs are activated by phosphorylation on both threonine and tyrosine residues within the motif Thr-Xaa-Tyr (18). The Xaa represents Glu in the ERK subfamily, Pro in the JNK subfamily, and Gly in the p38 MAPK subfamily. Both the threonine and tyrosine residues are phosphorylated by a dual-specificity kinase or MKK. The central residue in the Thr-Xaa-Tyr motif allows for selective activation by different MKKs, such that MEK1 and MEK2 selectively phosphorylate and activate the ERKs; MKK4/SEK1 and MKK7 phosphorylate and activate JNK; and MKK3 and MKK6 phosphorylate and activate p38 MAPK (19, 20, 21, 22, 23). Many studies have shown that the phosphorylation of MAPK on both Thr and Tyr correlates very closely with enzyme activity. Recently, it has been shown that GnRH is capable of activating the MAPKs in whole-cell lysates from primary pituitary cultures (24, 25) and gonadotrope cell lines (26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36).
Upon activation, MAPKs dimerize and translocate to the nucleus (37). Once in the nucleus, the MAPKs phosphorylate and activate nuclear transcription factors involved in DNA synthesis and cell division leading to the induction of immediate-early response genes including c-fos, c-jun, and Egr-1. The fos/jun heterodimer binds to AP-1 sites, and the Egr-1 factor binds to GC-rich elements on various promoters to induce the transcription of downstream genes. Recent evidence indicates that GnRH can stimulate c-fos and Egr-1 expression in primary pituitary cells (38), and
T31 cells (39, 40, 41), leading to the suggestion that some GnRH transcriptional effects could be mediated by these immediate-early genes. In
T31 gonadotrope cells, MAPK may be involved in the GnRH regulation of the
-subunit gene (29, 30). GnRH also regulates the transcriptional activities of LHß and FSHß chimeric reporter genes in the same cell line, possibly through differential use of PKC/MAPK and Ca2+ pathways (42, 43, 44, 45). However, the
T31 gonadotrope cell line does not express the LHß gene; therefore, it is not possible to study the regulation of the native promoter. The LßT2 gonadotrope cell expresses both LHß and FSHß genes, so can be used to study the regulation of transfected native promoters (7, 8). Both promoters are induced by GnRH, but the exact signaling pathways involved are not clearly understood. Consequently, we investigated whether GnRH stimulates the activity of the MAPK subfamilies, causes translocation of activated ERK, and/or induces expression of c-fos and LHß proteins in LßT2 cells.
 |
RESULTS
|
---|
GnRH Activates MAPK Cascades in LßT2 Cells
GnRH has been shown to activate the three MAPK families, including ERK1 and 2, p38 MAPK, and JNK in the
T31, GGH3, and Cos-7/GnRHR cell lines. We tested whether these kinases are activated by GnRH in the LßT2 pituitary gonadotrope cell line. Serum-starved cells were treated with 100 nM GnRH for increasing periods. Whole-cell lysates were immunoblotted for the dually phosphorylated forms of ERK, JNK, and p38. The blots were then stripped and reprobed with antibodies for ERK1/2 protein, JNK2 protein, and p38 protein, respectively, to confirm equivalent sample loading. GnRH stimulated a rapid and very strong increase in ERK phosphorylation that was visible by 1 min (50-fold), reached its peak at 10 min (60-fold), and then declined over 90 min (Fig. 1A
). GnRH also stimulated p38 phosphorylation very strongly with a similar time course reaching 17-fold at 1 min with a maximum 30-fold at 10 min (Fig. 1C
). In contrast, GnRH-induced JNK phosphorylation was much weaker, reaching only 10-fold at 30 min (Fig. 1B
). Similar amounts of ERK, p38, and JNK2 were loaded in all lanes (bottom panels). A similar time course of ERK, p38, and JNK activation was observed in the related LßT4 gonadotrope cell line (data not shown).

View larger version (58K):
[in this window]
[in a new window]
|
Figure 1. GnRH Activates MAPK Subfamilies in LßT2 Cells
A, Time course of GnRH-stimulated ERK activation in LßT2 cells. LßT2 cells were incubated in serum-free DMEM overnight before treatment with 100 nM GnRH for 0, 1, 5, 10, 15, 30, 60, 90, or 120 min. Whole-cell lysates were separated by SDS-PAGE and immunoblotted with an antibody for phospho-ERK1/2 (top panel). GnRH stimulates ERK phosphorylation 50-fold by 1 min, increasing to a maximum of 60-fold by 10 min. The blots were then stripped and reblotted with an antibody to ERK1/2 to determine total ERK1/2 protein loading (bottom panel). B, Time course of GnRH-stimulated JNK activation in LßT2 cells. Whole-cell lysates were separated by SDS-PAGE and immunoblotted with an antibody for phospho-JNK1/2 (top panel). GnRH caused a 10-fold increase in JNK phosphorylation at 30 min. The blots were then stripped and reblotted with an antibody to JNK2 to determine total protein loading (bottom panel). C, Time course of GnRH-stimulated p38 kinase activity in LßT2 cells. Whole-cell lysates were separated by SDS-PAGE and immunoblotted with an antibody for phospho-p38MAPK (top panel). GnRH stimulates p38MAPK phosphorylation 17-fold at 1 min, increasing to a maximum of 30-fold at 10 min. The blots were then stripped and reblotted with an antibody to p38MAPK to determine total protein loading (bottom panel). The blots are representative experiments each repeated twice.
|
|
GnRH Activates ERK via PKC in LßT2 Cells
GnRH is thought to signal primarily via the Gq heterotrimeric G protein complex leading to calcium elevation and activation of PKC. First, we examined whether artificial activation of PKC and calcium signaling could induce ERK phosphorylation. PKC signaling was activated by treatment with 100 nM phorbol-12-myristate-13-acetate (PMA), and calcium was elevated by treatment with 50 mM KCl for 5 min. Whole-cell lysates were immunoblotted with the antibody to dually phosphorylated active ERK as before. GnRH, PMA, and KCl all induced the activation of ERK in LßT2 cells (Fig. 2A
). GnRH and KCl activated ERK to similar extents, but PMA activation was noticeably stronger than GnRH (2-fold). This indicated that GnRH could potentially signal through either pathway in LßT2 cells.

View larger version (57K):
[in this window]
[in a new window]
|
Figure 2. Stimulation of ERK1/2 by GnRH, PMA, or KCl
A, ERK phosphorylation by GnRH, PMA, and KCl. LßT2 cell were serum-starved overnight and then stimulated with 100 nM GnRH, 100 nM PMA, or 50 mM KCl for 5 min. Whole-cell lysates were separated by SDS-PAGE and immunoblotted with antibodies for phospho-ERK1/2 (top panel). GnRH and KCl stimulated ERK phosphorylation equally, but PMA was a stronger agonist causing a 2-fold greater activation. The blots were stripped and reblotted for ERK1/2 protein, demonstrating equivalent protein loading (bottom panel). B, GnRH stimulates ras GTP loading. Serum-starved LßT2 cells were stimulated with 100 nM GnRH, 20 ng/ml PDGF, 100 nM PMA, or 50 mM KCl for 5 min. GTP-bound ras was precipitated from clarified cell lysates using a GST fusion protein containing the ras-binding domain of Raf. Immunoprecipitated proteins were immunoblotted for ras with a pan-ras antibody and quantified by densitometry. PDGF caused a 3.6-fold increase in GTP-ras; GnRH and PMA both caused 2.5-fold increases, but KCl caused only a 1.3-fold increase. Blot is representative of two experiments. C, Inhibition of ERK phosphorylation. LßT2 cells were serum-starved overnight and then pretreated with the following inhibitors for 30 min: 1 µM BIM-1 (BIM), 20 µM PD98059 (PD), 50 µM BAPTA-AM (BAPTA), or 20 µM LY 294002 (LY), and stimulated with 100 nM GnRH for 5 min. Whole-cell extracts were separated by SDS-PAGE and immunoblotted with an antibody to phospho-ERK1/2 (top panel). The blots were stripped and reblotted for ERK1/2 protein, demonstrating equivalent loading (bottom panel). ERK activation was quantified by densitometry. Inhibition of MEK with PD98059 caused a greater than 95% reduction of ERK phosphorylation, and inhibition of PKC with BIM-1 caused a 40% inhibition. Other reagents had no effect. These blots are representative of two experiments. D, Inhibition of ERK activation by EGTA, BAPTA, and nimodipine. LßT2 cells were serum-starved overnight and then pretreated with the following inhibitors: 50 µM BAPTA-AM (BAPTA) or 10 µM nimodipine (NIMO) for 30 min, or 3 mM EGTA for 15 min. Cells were then stimulated with 100 nM GnRH, 100 nM PMA, 50 mM KCl, or 10 µM ionomycin (Iono) for 5 min. Whole-cell extracts were separated by SDS-PAGE and immunoblotted with an antibody to phospho-ERK1/2. Blots were stripped and reblotted for ERK protein to verify equal loading (data not shown). E, Inhibition of MEK with U0126 blocks activation of ERK. LßT2 cells were serum starved overnight and then pretreated with 1 µM U0126 for 30 min. Cells were then stimulated with 100 nM GnRH, 100 nM PMA, or 50 mM KCl for 5 min. Whole-cell extracts were separated by SDS-PAGE and immunoblotted with an antibody to phospho-ERK1/2. Blots were stripped and reblotted for ERK protein to verify equal loading.
|
|
Most growth factors and mitogens activate the ERKs by the sequential activation of the small GTP-binding protein ras, the serine/threonine kinase Raf1, and the dual-specificity kinase MEK1 that directly phosphorylates ERK1 and 2. However, it has been shown that PKC activation by Gq-coupled receptors can induce the ERK cascade via the direct phosphorylation of Ser338 and Ser499 of Raf-1, effectively bypassing ras (46, 47, 48). We tested whether GnRH causes GTP loading and activation of ras. Serum-starved cells were treated for 5 min with 100 nM GnRH, 100 nM PMA, 50 mM KCl, or 20 ng/ml platelet-derived growth factor (PDGF) as a positive control. Cells were lysed and GTP-bound ras was precipitated using a glutathione-S-transferase (GST)-fusion protein containing the GTP-ras binding domain of Raf, followed by immunoblotting with a pan-ras antibody. PDGF caused a 3.6-fold increase in GTP-bound ras (Fig. 2B
). GnRH and PMA caused a similar 2.5-fold increase, but KCl did not cause a significant activation of ras. The lack of a response to calcium elevation may be related to the observation that
T31 and LßT2 cells express low levels of the calcium-dependent tyrosine kinase Pyk2 that mediates ras activation in other cells (Ref. 49 and our unpublished data).
A panel of pharmacological inhibitors was used to identify the signaling pathways involved in the activation of ERK by GnRH. Serum-starved cells were pretreated for 30 min with the PKC inhibitor bisindolylmaleimide I [BIM-1 (1 µM)], the MEK inhibitor PD98059 (20 µM), the cell-permeable calcium chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid acetoxymethyl ester [BAPTA-AM (50 µM)], or the PI3K inhibitor LY294002 (20 µM) and then treated with 100 nM GnRH for 5 min. Whole-cell lysates were immunoblotted for active ERK as before. The MEK inhibitor PD98059 blocked activation of ERK almost completely (>95%) as expected. The PKC inhibitor BIM-1 caused a 40% reduction, indicating that ERK activation is partially mediated by conventional PKC isoforms (Fig. 2C
). Chelation of intracellular calcium with BAPTA-AM had no effect, nor did inhibition of PI3K with LY294002. We were particularly intrigued by the lack of effect of calcium chelation, as calcium has been shown to be important in
T31 cells. To examine the calcium requirement more closely, cells were pretreated with EGTA (3 mM) to chelate extracellular calcium, nimodipine (10 µM) to block L-type calcium channels, or BAPTA-AM (50 µM) to chelate intracellular calcium. Cells were then stimulated with either GnRH, PMA to activate PKC, KCl to depolarize the cell, or ionomycin (10 µM) to elevate calcium. Whole-cell lysates were blotted for dually phosphorylated ERK (Fig. 2D
). EGTA caused a 30% reduction in GnRH stimulation, but nimodipine and BAPTA were without effect. PMA stimulation was not altered by any of the agents. The depolarization-induced increase in phospho-ERK with KCl was blocked more than 80% by chelation of extracellular calcium as expected, but was blocked only 50% by nimodipine or BAPTA. Ionomycin- induced ERK phosphorylation was blocked more than 80% by EGTA but not at all by nimodipine or BAPTA, consistent with the passive entry of calcium into the cells with ionomycin. These data suggest that GnRH-induced activation of ERK in LßT2 cells is mediated partially by PKC and may require calcium influx, but not via L-type calcium channels. Depolarization- induced ERK activation was more effectively blocked by EGTA than nimodipine, suggesting that other non- L-type calcium channels may be involved. This is consistent with our finding that the L-type channel agonist Bay-K 8644 is a much weaker activator of ERK than KCl (data not shown).
Inhibition of ERK activation by PD98059 implicated MEK in GnRH signaling. To confirm that GnRH activates ERK via the Raf-MEK pathway, cells were treated with the structurally unrelated MEK inhibitor U0126 that effectively inhibits both MEK1 and MEK2. Pretreatment of LßT2 cells with 1 µM U0126 prevented the activation of ERK by GnRH, PMA, and KCl, showing that all three agonists signal via MEK (Fig. 2E
).
GnRH Stimulates Accumulation of Active ERK in the Nuclei of LßT2 Cells
ERKs are a family of protein serine/threonine kinases that transduce signals from the cell surface to the nucleus in response to a variety of extracellular stimuli. ERK1 and 2 have been shown to translocate to the nucleus when phosphorylated, where they activate nuclear transcription factors. We used an immunofluorescent staining technique using antibodies to the dually phosphorylated ERKs to assess the translocation of activated phospho-ERK to the nucleus after GnRH stimulation. LßT2 cells were plated on coverslips, rendered quiescent by serum starvation, and then stimulated with 100 nM GnRH, 100 nM PMA, or 50 mM KCl for 5 min. Cells were stained with the antibody to active ERK followed by a rhodamine-conjugated secondary antibody, counterstained with Hoechst 33258 to highlight the nuclei, and visualized by fluorescence microscopy. In the basal state, very little staining for active phospho-ERK was detected (Fig. 3A
, left panels). GnRH stimulation caused the appearance of activated phospho-ERK in the nucleus of many LßT2 cells; similar results were obtained with PMA treatment (Fig. 3A
, middle panels). Elevation of calcium with KCl failed to cause nuclear phospho-ERK staining (Fig. 3A
, right panels) despite activation of ERK in whole-cell lysates by Western blot (Fig. 2
), indicating that an additional signal is required for nuclear localization.

View larger version (60K):
[in this window]
[in a new window]
|
Figure 3. GnRH Stimulates Accumulation of phospho-ERK in the Nucleus
A, GnRH, PMA, and KCl stimulate nuclear phospho-ERK. LßT2 cells were plated on acid-washed coverslips and then serum starved overnight. Cells were stimulated with 100 nM GnRH, 100 nM PMA, or 50 mM KCl for 5 min at 37 C, and then fixed and processed for immunofluorescence. Active-ERK was visualized by antibodies against dually phosphorylated ERK and rhodamine-labeled antirabbit secondary antibodies (top panels). Nuclei were stained with Hoechst 33258 DNA dye (bottom panels). Representative fields of cells are shown. B, Inhibition of nuclear ERK phosphorylation. LßT2 cells were plated on acid-washed coverslips and then serum starved overnight. Cells were pretreated with the following inhibitors: 1 µM BIM-1 (BIM), 20 µM PD98059 (PD), 50 µM BAPTA-AM (BAPTA), 10 µM nimodipine (NIMO), 20 µM LY 294002 (LY), or 10 µM SB203580 (SB) for 30 min, or 3 mM EGTA for 15 min, and then stimulated with 100 nM GnRH, 100 nM PMA, or 50 mM KCl for 5 min at 37 C. Cells were fixed and processed for immunofluorescence as above. Cells with nuclear fluorescence were scored as positive for phospho-ERK translocation. C, GnRH causes translocation of phospho-ERK by fractionation. LßT2 cells were serum starved, treated with 1 µM BIM-1 for 30 min, and then stimulated by 100 nM GnRH for 5 min. Cells were separated into nuclear and cytoplasmic fractions, and then immunoblotted with antibodies to phospho-ERK. Blot is representative of three experiments with similar results. D, GnRH causes nuclear translocation of ERK2. LßT2 cells were plated on acid-washed coverslips and then serum-starved overnight. Cells were pretreated with 1 µM BIM-1 for 30 min and then stimulated with 100 nM GnRH for 5 min at 37 C. Cells were fixed and stained with an antibody for ERK2 and a rhodamine-labeled antirabbit secondary antibodies (top panels). Nuclei were stained with Hoechst 33258 DNA dye (bottom panels). Representative fields of cells are shown.
|
|
GnRH-Induced Nuclear Accumulation of Active ERK Requires PKC
The above immunoblotting of whole-cell lysates implicated the MEK, PKC, and calcium pathways in the GnRH activation of ERK. We then investigated the role of these pathways in the nuclear localization of active phospho-ERK in LßT2 cells. Serum-starved cells on glass coverslips were pretreated for 30 min with 1 µM BIM-1, 20 µM PD98059, 50 µM BAPTA-AM, 20 µM LY294002, 10 µM nimodipine, and 10 µM SB203580, or for 15 min with 3 mM EGTA, and then stimulated with 100 nM GnRH, 100 nM PMA, or 50 mM KCl. Cells were fixed and stained with the antibody to the dually phosphorylated active form of ERK, counter stained for DNA, and visualized by fluorescence microscopy. Cells with nuclear staining for phospho-ERK were counted. Less than 5% of the cells are positive for phospho-ERK staining in the basal state and after KCl treatment (Fig. 3B
). GnRH and PMA cause nuclear phospho-ERK staining in approximately 60% of cells. Inhibition of conventional PKC isoforms with BIM-1, or MEK with PD98059, completely blocked both the GnRH- and PMA-stimulated nuclear localization of phospho-ERK. As for the whole-cell immunoblotting, chelation of intracellular calcium with BAPTA-AM, chelation of extracellular calcium with EGTA, blockade of L-type calcium channels with nimodipine, inhibition of PI3K with LY294002, or inhibition of p38MAPK with SB203580 had no effect on nuclear staining for phospho-ERK.
To confirm a role for conventional PKCs in the nuclear localization of activated ERK, LßT2 cells were pretreated with vehicle or the PKC inhibitor BIM-1 (1 µM) for 30 min, and then stimulated with 100 nM GnRH for 5 min. The cells were fractionated into nuclear and cytoplasmic extracts, and equal amounts of protein were immunoblotted with the antibody against the active dually phosphorylated form of ERK (Fig. 3C
). GnRH treatment causes the appearance of phospho-ERK in both the cytoplasmic and nuclear fractions. Inhibition of PKC signaling blocks the appearance of phospho-ERK in the nuclear fraction by 90% but has no effect on the cytoplasmic fraction (Fig. 3C
). The nuclear accumulation of ERK was also monitored by immunofluorescence using antibodies to ERK2 protein (Fig. 3D
). In basal, unstimulated cells most ERK2 staining is observed in the cytoplasm with very little in the nucleus. Upon GnRH stimulation, ERK2 redistributes so that staining is uniform over both the cytoplasm and nucleus. Pretreatment with the PKC inhibitor BIM-1 prevents the redistribution of ERK2 so that the staining is identical with that of basal cells (Fig. 3D
).
The complete inhibition of nuclear phospho-ERK staining by inhibition of PKC with BIM-1 was very striking. To confirm this finding, diacylglycerol (DAG)-dependent PKC isoforms were down-regulated by chronic treatment with the phorbol ester PMA. LßT2 cells were pretreated with 1 µM PMA or vehicle control for 16 h. Whole-cell extracts were immunoblotted for PKC isoforms. Blots were stripped and reblotted for ERK2 to control for protein loading. The
-, ß-,
-,
-,
-, and
-isoforms of PKC are expressed in LßT2 cells, and chronic PMA treatment reduced expression of the
-, ß-,
-, and
-isoforms by more than 90% and the
-isoform completely, but had no effect on the atypical DAG-independent
-isoform (Fig. 4A
). PMA-down-regulated cells were then stimulated with 100 nM GnRH for 5 min, and clarified cell lysates were immunoblotted for activation of ERK. PKC down-regulation reduces GnRH-stimulated ERK activation by more than 75% (Fig. 4B
). The inhibition of ERK is somewhat greater than that observed with BIM-1, presumably because PMA down-regulates both the conventional PKCs and the novel PKC isoforms
and
that are less sensitive to BIM-1 inhibition. To confirm that PKC down-regulation blocks nuclear phospho-ERK staining, PMA-down-regulated cells were stimulated with 100 nM GnRH or 100 nM PMA for 5 min, and then fixed and stained for phospho-ERK as above. Unlike acute PMA treatment, chronic treatment with 1 µM PMA does not lead to nuclear localization of active ERK. Chronic PMA treatment, however, completely abolishes the subsequent acute GnRH and PMA-stimulated nuclear staining of phospho-ERK (Fig. 4C
). These data strongly support the conclusion that GnRH activation of ERK is dependent on conventional DAG-sensitive PKCs in LßT2 cells.

View larger version (44K):
[in this window]
[in a new window]
|
Figure 4. PKC Down-Regulation by Chronic PMA Treatment Inhibits ERK Activation
A, Down-regulation of PKC isoforms. LßT2 cells were pretreated with PMA (1 µM) or vehicle for 16 h. Whole-cell lysates were separated by SDS-PAGE and blotted for the -, ß-, -, -, -, -, -, and -isoforms of PKC. Blots were stripped and reblotted for ERK2 to demonstrate equal protein loading. B, LßT2 cells were pretreated with PMA (1 µM) or vehicle for 16 h and then stimulated with 100 nM GnRH or 100 nM PMA for 5 min. Clarified cell lysates were separated by SDS-PAGE and immunoblotted with an antibody for phospho-ERK1/2 (top panel). The blots were then stripped and reblotted with an antibody to ERK1/2 to determine total ERK1/2 protein loading (bottom panel). C, LßT2 cells were pretreated with PMA (1 µM) or vehicle for 16 h and then stimulated with 100 nM GnRH or 100 nM PMA for 5 min. Cells were fixed and processed for immunofluorescence as above. Down-regulation of PKC blocked the induction of nuclear phospho-ERK by both GnRH and PMA. Results are the mean ± SEM of three experiments and are presented as percent of cells positive for nuclear translocation.
|
|
GnRH Induces c-fos Expression via MEK and Calcium in LßT2 Cells
The ras-MAPK cascade is important for the induction of immediate-early genes such as c-fos and Egr-1 that are involved in proliferation. It has been shown that stimulation with GnRH results in increased mRNA and protein for the immediate-early genes c-fos and c-jun in
T31 cells, and Egr-1 in LßT2 cells. Therefore, we examined the effect of GnRH, PMA, or KCl on c-fos protein expression. Serum-starved LßT2 cells were stimulated with 100 nM GnRH, 100 nM PMA, or 50 mM KCl for 60 min. Whole-cell lysates were then immunoblotted for c-fos (Fig. 5A
). All three agonists were able to stimulate c-fos protein expression (13-fold for GnRH, 9-fold for PMA, and 6-fold for KCl).

View larger version (29K):
[in this window]
[in a new window]
|
Figure 5. Stimulation of Whole-Cell c-fos Expression by GnRH, PMA, or KCl
A, GnRH, PMA, and KCl stimulate c-fos expression. LßT2 cell were serum starved overnight and then stimulated with 100 nM GnRH, 100 nM PMA, or 50 mM KCl for 5 min. Whole-cell lysates were separated by SDS-PAGE and immunoblotted with antibodies for c-fos. GnRH, PMA, and KCl stimulated c-fos expression 13-fold, 9-fold, and 6-fold, respectively. B, Inhibition of c-fos expression. LßT2 cells were serum-starved overnight and then pretreated with the following inhibitors for 30 min: 1 µM BIM-1 (BIM), 20 µM PD98059 (PD), 50 µM BAPTA-AM (BAPTA), 20 µM LY 294002 (LY), or 10 µM SB203580 (SB). Cells were stimulated with vehicle or 100 nM GnRH for 5 min. Whole-cell extracts were separated by SDS-PAGE and immunoblotted with an antibody to c-fos. Inhibition of MEK with PD98059 causes a 70% reduction in c-fos levels. Chelation of intracellular calcium with BAPTA-AM, or extracellular calcium with EGTA, reduces GnRH- induced c-fos expression 90% and 80%, respectively. Inhibition of PI3K with LY294002, PKC with BIM-1, or p38 MAPK with SB203580 did not alter induction of c-fos. These blots are representative of two experiments.
|
|
Since GnRH-induced ERK activation is PKC dependent, we determined whether PKC signaling is also involved in the GnRH-induced c-fos expression in LßT2 cells. Serum-starved cells were pretreated with 1 µM BIM-1, 20 µM PD98059, 50 µM BAPTA-AM, 20 µM LY294002, and 10 µM SB203580 for 30 min, or 3 mM EGTA for 15 min, followed by stimulation with 100 nM GnRH for 60 min. Whole-cell lysates were immunoblotted with an antibody to c-fos as before (Fig. 5B
). Inhibition of MEK with PD98059 causes a 70% reduction in c-fos levels. Inhibition of PKC with BIM-1, which completely blocks the nuclear staining of phospho-ERK, surprisingly does not block the induction of c-fos by GnRH. Conversely, chelation of intracellular calcium with BAPTA-AM, or extracellular calcium with EGTA, neither of which had any effect on ERK activation, completely blocked GnRH-induced c-fos expression (>90% for BAPTA, >80% for EGTA). As for MAPK, inhibition of PI3K with LY294002, or p38 MAPK with SB203580, had no effect on induction of c-fos.
To confirm the immunoblotting results, we used single-cell immunofluorescent staining to examine the nuclear expression of c-fos. LßT2 cells were plated on coverslips, rendered quiescent by serum starvation, and then stimulated with 100 nM GnRH, 100 nM PMA, or 50 mM KCl for 60 min. Cells were fixed and stained for c-fos, then counterstained for DNA, and visualized by fluorescence microscopy. Cells that were positive for nuclear c-fos staining were counted. Very few cells (<5%) stained for c-fos in the basal unstimulated state (Fig. 6A
). GnRH and PMA were both able to cause c-fos staining in the majority (>70%) of cell nuclei. KCl was also able to induce c-fos staining but to a lesser extent (
50%).

View larger version (104K):
[in this window]
[in a new window]
|
Figure 6. GnRH, PMA, and KCl Induce Nuclear Expression of c-fos
A, GnRH, PMA, and KCl stimulate nuclear c-fos staining. LßT2 cells were plated on acid-washed coverslips and starved overnight in serum-free DMEM. Cells were stimulated with 100 nM GnRH, 100 nM PMA, or 50 mM KCl for 60 min. Nuclear c-fos expression was visualized using a rabbit anti-c-fos antibody followed by a rhodamine-conjugated secondary antibody (top panels). Nuclei were stained with Hoechst 33258 DNA dye (bottom panels). Representative fields of cells are shown. B, Inhibition of nuclear c-fos staining. LßT2 cells were serum starved overnight and then pretreated with the following inhibitors: 1 µM BIM-1 (BIM), 20 µM PD98059 (PD), 1 µM U0126, 50 µM BAPTA-AM (BAPTA), 10 µM nimodipine (NIMO), 20 µM LY294002 (LY), or 10 µM SB203580 (SB) for 30 min, or 3 mM EGTA for 15 min. Cells were stimulated with 100 nM GnRH, 100 nM PMA, or 50 mM KCl for 60 min and processed for immunofluorescence as above. Cells with nuclear c-fos immunofluorescence were counted. C, Down-regulation of PKC. LßT2 cells were pretreated with vehicle or PMA (1 µM) for 16 h and then stimulated with 100 nM GnRH or 100 nM PMA for 60 min as processed for immunofluorescence as above. Cells with nuclear c-fos immunofluorescence were counted. Results are the mean ± SEM of three experiments and are presented as percent of cells positive for c-fos staining.
|
|
As for the whole-cell immunoblotting, cells were pretreated with inhibitors before stimulation as above. Coverslips were fixed and stained for nuclear c-fos (Fig. 6B
). Inhibition of PKC with BIM-1 again did not inhibit the GnRH stimulation of c-fos although the PMA effect was abrogated completely. BIM-1 also had no effect on the ability of KCl to stimulate c-fos, showing that this calcium effect is not mediated by PKC. Inhibition of MEK with PD98059 or U0126 blocked the effects of either PKC or calcium on c-fos expression, but only caused a partial (65%) inhibition of the GnRH effect. This suggests that GnRH has effects on c-fos expression that, unlike effects on MAPK, are independent of MEK. Chelation of intracellular calcium with BAPTA-AM completely inhibited c-fos staining with all three agonists. Inhibition of L-type calcium channels with nimodipine or chelation of extracellular calcium with EGTA prevented the KCl-induced increase in c-fos as expected, had no effect on the PMA induction, and reduced the GnRH effect by 50%. Inhibition of PI3K or p38MAPK had no effect on c-fos induction by GnRH.
To confirm the effect of the PKC inhibitor BIM-1 in the induction of c-fos, LßT2 cells were pretreated with 1 µM PMA for 16 h to down-regulate the DAG-sensitive isoforms of PKC, and then exposed to 100 nM GnRH or 100 nM PMA for 60 min. As expected, PMA-induced c-fos expression was completely abolished by PKC depletion, whereas GnRH still induced c-fos expression in 40% of the PKC-depleted cells (Fig. 6C
). Because the number of positive cells after GnRH stimulation is reduced by 30%, signaling by DAG-dependent PKC isoforms that are not BIM-1 sensitive may be required for full induction. The concentration of BIM used in these experiments should efficiently inhibit the conventional
-, ß-, and
-isoforms of PKC, but not the novel isoforms
,
, and
that are present in these cells. This observation suggests that novel, but not conventional PKC isoforms may play an important role in regulating GnRH-induced c-fos expression in LßT2 cells.
GnRH Induces LHß Protein via MEK and Calcium in LßT2 Cells
The LßT2 cells express both LHß and FSHß mRNAs and secrete mature LH in response to GnRH. The LHß mRNA is also induced by both GnRH and steroid hormones (8). We used immunofluorescence to examine LHß protein expression in these cells. LßT2 cells were plated on coverslips, rendered quiescent by serum starvation, and stimulated overnight with 100 nM GnRH, 100 nM PMA, or 50 mM KCl. Cells were fixed and stained for LHß, and then counterstained for DNA and visualized by fluorescence microscopy (Fig. 7A
). LHß staining is observed in the perinuclear region consistent with the localization of the protein in secretory vesicles. Basal cells show staining in 18% of cells. Stimulation with GnRH, PMA, or KCl doubles the number of LHß-positive cells. A time course for GnRH induction of LHß protein was performed (Fig. 7B
). A single dose of 100 nM GnRH was administered for 1, 2, 4, 8, or 24 h, and the number of LHß positive cells was counted. An increase in the number of LHß-positive cells is apparent by 2 h and reaches a maximum at 8 h, which is maintained for up to 24 h. Thus, protein expression is induced very rapidly after GnRH stimulation. A GnRH dose-response curve was then determined. Cells were treated with increasing doses of GnRH for 16 h and then fixed and stained for LHß (Fig. 7C
). An increase in the number of LHß-positive cells is first apparent at 1 nM GnRH; the ED50 for the induction of LHß is approximately 3 nM.

View larger version (58K):
[in this window]
[in a new window]
|
Figure 7. GnRH, PMA, and KCl Stimulate LHß Protein Expression
A, GnRH, PMA, and KCl stimulate LHß protein expression. LßT2 cells were plated on acid-washed coverslips and starved overnight in serum-free DMEM. Cells were stimulated with 100 nM GnRH, 100 nM PMA, or 50 mM KCl overnight. LHß protein expression was visualized using a rabbit anti-LHß antibody followed by a TRITC-conjugated secondary antibody (top panels). Nuclei were stained with Hoechst 33258 DNA dye (bottom panels). Representative fields of cells are shown. B, Time course of LHß protein expression by GnRH in LßT2 cells. LßT2 cells were stimulated with 100 nM GnRH for the times indicated and processed for immunofluorescence as above. Cells with perinuclear LHß staining were counted, and results are expressed as percent positive (mean ± SEM). C, GnRH dose-response for LHß protein induction. Cells were stimulated with GnRH for 16 h at the indicated concentrations and processed for immunofluorescence as above. Cells with perinuclear LHß staining were counted, and results are expressed as percent positive (mean ± SEM). D, Inhibition of LHß protein expression. LßT2 cells were serum starved overnight and then pretreated with the following inhibitors for 30 min: 1 µM BIM-1 (BIM), 20 µM PD98059 (PD), 1 µM U0126, 10 µM nimodipine (NIMO), 20 µM LY294002 (LY), or 10 µM SB203580 (SB). Cells were stimulated with 100 nM GnRH, 100 nM PMA, or 50 mM KCl overnight and processed for immunofluorescence as above. Cells with perinuclear LHß staining were counted and results are expressed as percent positive. The results are the mean ± SEM of three similar experiments each with triplicate determinations.
|
|
To examine which signaling pathways might be involved in the LHß protein expression in LßT2 cells, serum-starved LßT2 cells were pretreated for 30 min with 20 µM PD98059, 1 µM U0126, 1 µM BIM-1, 10 µM nimodipine, 20 µM LY294002, or 10 µM SB203580, and then stimulated with 100 nM GnRH, 100 nM PMA, or 50 mM KCl for 16 h. Cells were fixed and stained for LHß as before (Fig. 7D
). Inhibition of MEK with PD98059 or U0126 blocked the increase in LHß- positive cells with all three agonists. Inhibition of PKC with BIM-1 blocked only the increase with PMA, but not GnRH or KCl. Blockade of L-type calcium channels with nimodipine prevented the GnRH or KCl-stimulated increase in LHß-positive cells but had no effect on the PMA stimulation. Chelation of intracellular calcium with BAPTA-AM or extracellular calcium with EGTA, as used in the earlier experiments, was toxic to the cells over the extended period required for induction of LHß protein and caused the cells to detach from the coverslip (data not shown). We were also unable to test down-regulation of PKC, as overnight treatment with PMA alone induced LHß expression. Inhibition of PI3K or p38MAPK did not prevent the induction of LHß protein by GnRH.
 |
DISCUSSION
|
---|
GnRH binds to a specific high-affinity receptor on pituitary gonadotrope cells to initiate signaling cascades leading to the induction of various genes, secretion of LH and FSH, and control of reproductive function. In this paper, we demonstrate that GnRH activates the three MAPK subfamilies in LßT2 cells. Phosphorylation and activation of both ERK and p38MAPK are stimulated rapidly and strongly, but activation of JNK is slower and weaker. Similar time courses for the induction of ERK and JNK in
T31 and LßT2 cells, and p38MAPK in
T31 cells, have been published previously (24, 25, 26, 27, 28, 29, 30, 31). We show here that activation of ERK by GnRH in LßT2 cells is partially blocked by inhibition of conventional PKC signaling, either using BIM-I or by down-regulation of PKC with chronic PMA treatment, in agreement with previous reports (30, 31, 34, 49, 50). PKC signaling may activate the ERK pathway at two potential points. We demonstrate here that phorbol esters can activate ras in LßT2 cells. Phorbol esters can also activate Raf in the absence of ras activation by direct phosphorylation (46, 47, 48). Phosphorylation of Ser338 or Raf-1 may be mediated by the novel isoforms PKC
and -
that cause prolonged activation of ERK (51, 52, 53). The ras protein may still be required to target Raf to the membrane, however, to allow phosphorylation by PKC (54). Ser338 is also the target of the kinases Pak-1 and Pak-3, which are activated downstream of PI3K and Rac and cause activation of ERK (55, 56). Phosphorylation of Ser338 by novel PKCs may explain why inhibition of PKC with BIM-1 reduces ERK activation by 40% but PMA down-regulation reduces ERK activation by 75%. The novel PKCs are less sensitive to BIM-1 than conventional PKCs but are efficiently down-regulated by chronic PMA.
Calcium elevations have been shown to activate ERK in a number of cells, but the mechanism is unclear. In PC12 cells, calcium elevation induced by depolarization can activate both the classical ras pathway by activating either the epidermal growth factor receptor, Pyk2, or RasGRF, and a novel calmodulin-dependent pathway activating MEK in a Raf-independent manner (57). We did not find evidence for ras activation with depolarization of LßT2 cells but ERK is activated strongly. GnRH has been shown to cause both release of intracellular calcium and influx of extracellular calcium in LßT2 cells. Is either of these calcium signals important for ERK activation? Preventing calcium influx with EGTA causes only a very modest (30%) reduction in ERK activation by GnRH, and chelation of intracellular calcium with BAPTA-AM or blockade of L-type calcium channels with nimodipine has no effect on ERK activation. This is in contradiction to recent reports from two groups. Mulvaney and co-workers (32, 33) reported that inhibition of the initial calcium transient in
T31 cells using BAPTA-AM or thapsigargin does not inhibit GnRH-stimulated ERK activation, in agreement with our findings in LßT2 cells. However, they found that sustained calcium elevation via influx through voltage-gated calcium channels is necessary for ERK activation in both
T31 and primary pituitary cells, as it is almost completely blocked by EGTA or the L-type channel blocker nifedipine (33). Our results in LßT2 cells differ in that EGTA has only a small effect, and the channel blocker nimodipine has no effect on ERK activation. This may indicate an important difference between the immortalized LßT2 cell line and primary gonadotrope cells. Interestingly, Mulvaney and associates (33) observed that depolarization of the cell with potassium did not activate ERK despite sustained calcium elevation, but activation of L-type calcium channels with Bay-K 8644 activated ERK very strongly in the presence of a nearly identical elevation of calcium. They suggested that either depolarization does not activate the same channels or that depolarization and Bay-K 8644 differ in the mechanism of activation. In contrast, we observed that depolarization is a strong activator of ERK in LßT2 cells and that Bay-K 8644 is a very weak activator. This would be consistent with L-type channels playing a minor role in signaling to ERK in this cell type. More importantly, Yokoi et al. (36) reported that GnRH activation of ERK in LßT2 cells, the same cells used for our study, is dependent on calcium as it is blocked completely by EGTA, BAPTA-AM, or nifedipine. Why do our results in the same cells differ? The previous study measured ERK activation by immunoprecipitation with an antibody to ERK1 followed by an in vitro kinase assay using myelin basic protein as substrate. ERK2 is the major isoform in the LßT2 cells and its possible that the antibody used didnt recognize this isoform, particularly as no controls were shown to demonstrate efficient immunoprecipitation. The ERKs have also been found in large signaling complexes assembled on scaffold proteins, which may also interfere with antibody recognition. In the present study, activation of ERK is measured by antibodies to the dually phosphorylated form of the enzyme on whole-cell lysates and thus would not be affected by the presence of large signaling complexes.
Activated ERK translocates to the nucleus in many cells, where it phosphorylates transcription factors of the ternary complex factor (Elk/SAP/ets) and nuclear receptor families. The mechanism of nuclear localization is poorly understood. Unphosphorylated inactive ERK is monomeric and is small enough to enter the nucleus by passive diffusion (37). Monomeric ERK is not retained in the nucleus, however, but is exported rapidly due to the presence of a nuclear export signal. Activation of ERK by phosphorylation causes dimerization, kinase activation, and accumulation in the nucleus. The ERK dimer is too large to enter the nucleus passively but is actively transported and retained in the nucleus. ERK kinase activity is not required for transport, as kinase-defective mutants are retained in the nucleus to the same extent as wild type (37). Import is via a Ran-dependent process, and ERK can interact with components of the nuclear pore complex (58). Retention in the nucleus requires dimerization, as mutant ERKs that fail to dimerize when activated do not accumulate in the nucleus. ERKs do contain a putative nuclear export sequence in the dimer interface that is hidden in the dimeric ERK. This is not the only mechanism, however, as mutation of this sequence does not result in nuclear retention of inactive ERK. The mechanism of transport of the dimerized ERK is not known. It may be that the nuclear localization sequence is intrinsic to dimeric ERK, or ERK may piggy-back into the nucleus in association with other proteins, or that ERK is retained in the cytoplasm by a scaffold protein.
We show here that GnRH or PMA stimulation of LßT2 cells causes an increase in phospho-ERK immunofluorescence that is localized exclusively to the nucleus. This nuclear staining is dependent on MEK and PKC. Depolarization of the cells with KCl does not lead to nuclear fluorescence despite strong activation of ERK by immunoblot, suggesting that calcium activates ERK by a different pathway. Inhibition of PKC only causes a partial reduction in ERK activation by immunoblot, but entirely eliminates nuclear staining and nuclear accumulation by subcellular fractionation. Thus, it appears that the nuclear accumulation of phospho-ERK requires a PKC signal that is distinct from that leading to activation. The sensitivity of the nuclear localization to the inhibitor BIM-1 might suggest that this signal is mediated by conventional PKC isoforms. Even in the presence of normal PKC signaling, the majority of phosphorylated ERK is present in the cytoplasm by fractionation after GnRH stimulation, but no cytoplasmic phospho-ERK immunofluorescence is observed under any conditions tested. We believe that most of the ERK is sequestered in the cytoplasm in large signaling complexes. Many components of the MAPK cascades are coordinated by scaffold proteins such as JIP1, MP-1, MEKK1, and ß-arrestin (59, 60, 61). The most likely explanation is that even though ERK may be phosphorylated in the cell, it is still bound in a signaling complex preventing the recognition of the epitope. Phosphorylation of a component of the complex by PKC may cause release of active ERK, allowing dimerization and nuclear translocation. We are currently investigating whether ERK is found associated with such a signaling complex and whether translocation of ERK to the nucleus requires a PKC-dependent signal.
We also examined the regulation of four known GnRH target genes, the immediate-early gene c-fos and the LHß, FSHß, and
-subunit genes. The laboratory of Marshall and associates (62) has demonstrated that pre-mRNA transcripts of LHß and FSHß in primary pituitary cells correlate very well with serum gonadotropin levels. If a causal relationship exists between transcription and secretion, which may or may not be the case, it would imply that changes in the expression of the ß-subunit proteins also correlate with circulating hormone levels. Expression of both c-fos and LHß proteins is induced by treatment with GnRH, or with PMA to activate PKC, or by depolarization with KCl. The
-subunit protein is detected in more than 50% of LßT2 cells in the basal state and does not increase with GnRH treatment (data not shown). This is consistent with the lack of induction of the
-subunit mRNA by Northern blot in this cell line (8). We were unable to detect expression of the FSHß protein even after GnRH treatment (data not shown), as the mRNA is expressed at extremely low levels (63). Inhibition of MEK reduced the induction of both c-fos and LHß proteins by GnRH, showing that both genes are induced partially via the Raf-MEK-ERK cascade. Inhibition of PKC with BIM-1 had no effect on the induction of either gene by GnRH, yet blocked the nuclear localization of active ERK. This is in contrast to
T31 cells where activation of MAPK correlated with induction of c-fos. Down-regulation of PKC, on the other hand, reduced the GnRH induction of c-fos, which may indicate the involvement of novel PKC isoforms, which are less sensitive to BIM-1 but have been shown to activate Raf directly and cause prolonged activation of ERK (53). Chelation of intracellular calcium had no effect on ERK activation but surprisingly eliminated the induction of c-fos. On this point the induction of c-fos by GPCRs or tyrosine kinase receptors differs, as chelation of intracellular calcium with BAPTA-AM prolongs the activation of ERK by epidermal growth factor (EGF) and enhances c-fos induction in mouse embryonic fibroblasts (64). Blockade of L-type calcium channels or chelation of extracellular calcium impaired the induction of c-fos by GnRH and prevented the induction of LHß, suggesting that influx of calcium as well as intracellular calcium is important. The pattern of inhibition was similar with the c-fos and LHß genes, which may indicate that GnRH signals via common calcium-dependent and MEK-dependent mechanisms to induce both genes.
The MEK dependence is noteworthy for a number of reasons. First, the MEK inhibitor implicates ERK in the induction of both genes. However, we have defined conditions in which activated ERK is excluded from the nucleus, arguing against the direct activation of nuclear transcription factors by ERK. One possible explanation is that activation of both c-fos and LHß genes is ERK dependent but via an intermediary kinase. A number of kinases including Rsk1, Rsk2, and Mnk1 can be activated by ERK. These kinases have also been shown to translocate to the nucleus upon activation. It is possible that one of these kinases is present in the signaling complex with MEK and ERK, is released upon activation by ERK, and translocates to the nucleus. Alternatively, the target transcription factor may be resident in the cytoplasm in quiescent cells and may translocate to the nucleus after phosphorylation by ERK, analogous to the nuclear translocation of the Smad (similar to mothers against decapentaplegic) and signal transducer and activator of transcription (Stat) transcription factors. Second, inhibition of MEK by either PD98059 or U0126 did not eliminate c-fos induction completely, indicating a parallel pathway signaling to the c-fos promoter. This may be via direct cdc42/Rac/Pak1 activation of the serum-response factor in the absence of ERK signaling that has been reported by Hill and Treisman (65), although additional studies will be necessary to investigate this non-MEK pathway.
In conclusion, we have shown that GnRH activates all three subfamilies of MAPKs to differing degrees and have identified a novel PKC-dependent translocation of activated ERK to the nucleus in LßT2 cells. We also found that expression of the c-fos and LHß proteins are coordinately regulated by GnRH via calcium and MEK-dependent pathways. This may have important implications for GnRH-regulated gene expression in gonadotropes, and studies are underway to determine whether other genes are under coordinate regulation in the LßT2 cells.
 |
MATERIALS AND METHODS
|
---|
Materials
GnRH was purchased from Sigma (St. Louis, MO). PMA, PD98059, BIM-1, BAPTA-AM, LY294002, U0126, nimodipine, and SB203580 were from Calbiochem (La Jolla, CA). Rabbit polyclonal anti-ACTIVE MAPK antibody and rabbit polyclonal anti-ACTIVE JNK antibody were from Promega Corp. (Madison, WI). Rabbit polyclonal anti-phospho-p38MAPK (Thr180/Tyr182) antibody was from Cell Signaling Technology (Beverly, MA). Rabbit polyclonal anti-c-fos antibody (sc-52) and horseradish peroxidase-linked antimouse and antirabbit antibodies were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Antibodies to individual isoforms of PKC were from BD-Transduction Laboratories, Inc. (San Diego, CA). Rabbit polyclonal anti-LHß antibody was kindly provided by Dr. A. F. Parlow at the National Hormone Pituitary Program (NHPP), NIDDK. Tetramethylrhodamine isothiocyanate (TRITC)- conjugated antirabbit antibodies were purchased from Jackson ImmunoResearch Laboratories, Inc. (West Grove, PA). All other reagents were purchased from either Sigma or Fisher Scientific (Pittsburgh, PA).
Cell Culture
LßT2 cells were maintained in monolayer cultures in DMEM supplemented with 10% FBS and antibiotics in humidified 10% CO2 at 37 C. Cells were starved overnight in serum-free DMEM and then pretreated with inhibitors PD98059 (20 µM), BIM-1 (1 µM), BAPTA-AM (50 µM), LY 294002 (20 µM), U0126 (1 µM), and SB203580 (10 µM) for 30 min at 37 C. Agonists GnRH (100 nM), PMA (100 nM), KCl (50 mM), or PDGF (20 ng/ml) were added for the appropriate period.
Immunostaining
For c-fos and LHß staining, LßT2 cells were plated on 10-mm acid-washed glass coverslips and stimulated with agonists and inhibitors as above. Cells were washed with PBS and fixed with 3.7% formaldehyde in PBS for 20 min at room temperature. After two washes in PBS, the cells were permeabilized and blocked in PBS containing 5% BSA and 0.5% Nonidet P-40 for 10 min. Coverslips were incubated with the rabbit anti-c-fos antibody (1:400 dilution) or rabbit anti-LHß antibody (1:1,200 dilution) for 60 min at room temperature, washed once in PBS, and then incubated with TRITC-conjugated antirabbit IgG antibody (1:100 dilution) in PBS with 5% BSA and 0.5% Nonidet P-40 for 30 min at room temperature. After a wash with PBS, coverslips were incubated with a DNA intercalating dye (Hoechst 33258, Sigma) diluted 1:250 for 60 min to stain nuclei. Finally, the coverslips were extensively washed with PBS, rinsed with water, and mounted in PBS containing 15% gelvatol (polyvinyl alcohol), 33% glycerol, and 0.1% sodium azide.
For phospho-ERK staining, cells were washed with PBS, fixed in 3.7% formaldehyde in PBS as above, and then washed with Tris-buffered saline (TBS)-Triton (50 mM Tris-HCL, pH 7.4, 150 mM NaCl, and 0.1% Triton X-100). The cells were permeabilized in 100% methanol at -20 C for 10 min, washed with TBS-Triton, and then blocked with 5% normal horse serum in TBS-Triton for 60 min at room temperature to reduce nonspecific staining. Coverslips were incubated with the anti-ACTIVE MAPK antibody at a 1:400 dilution in 5% BSA in TBS-Triton overnight at 4 C. The cells were washed with 0.1% BSA in TBS-Triton and then incubated with a TRITC-conjugated antirabbit IgG antibody at a 1:100 dilution in 3% BSA in TBS-Triton for 60 min at room temperature. Coverslips were washed with TBS-Triton and incubated with Hoechst 33258 dye (1:250 dilution) in TBS-Triton for 60 min at room temperature. The coverslips were washed and mounted as described above. Staining was visualized with an Axiophot fluorescence microscope (Carl Zeiss, Thornwood, NY) and photographed using the ISEE imaging system (Inovision, Raleigh, NC).
Western Blotting
LßT2 cells were grown to confluence in six-well plates, washed once with PBS, and incubated in serum-free DMEM overnight. For inhibition experiments, the cells were pretreated with PD98059 (20 µM), BIM-1 (1 µM), BAPTA (50 µM), LY294002 (20 µM), SB203580 (10 µM), or nimodipine (10 µM) for 30 min, or EGTA (3 mM) for 15 min at 37 C. Cells were stimulated with 100 nM GnRH, 100 nM PMA, or 50 mM KCl for various periods of time at 37 C. Thereafter, cells were washed with ice-cold PBS, and then lysed on ice in SDS sample buffer (50 mM Tris, 5% glycerol, 2% SDS, 0.005% bromophenol blue, 84 mM dithiothreitol, 100 mM sodium fluoride, 10 mM sodium pyrophosphate, and 2 mM sodium orthovanadate, pH 6.8), boiled for 5 min to denature proteins, and sonicated for 5 min to shear the chromosomal DNA. Equal volumes (3040 µl) of these lysates were separated by SDS-PAGE on 10% gels, electrotransferred to polyvinylidene difluoride (PVDF) membranes (Immobilon-P, Millipore Corp., Bedford, MA). The membranes were blocked with 5% BSA (for phospho-MAPK, -JNK, and -p38) or 5% nonfat dried milk (for c-fos and ras) in TBS-Tween (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.1% Tween-20). Blots were incubated with primary antibodies in blocking buffer for 60 min at room temperature, and then incubated with horseradish peroxidase-linked secondary antibodies followed by chemiluminescent detection. Anti-ACTIVE MAPK or anti-ACTIVE JNK antibodies were used at a 1:2,500 dilution; anti-phospho-p38, anti-ERK, anti-JNK2, anti-p38, anti-ras, or anti-c-fos antibodies were used at a dilution of 1:1,000. Antibodies to individual isoforms of PKC were used at a dilution of 1:1,000. For the phospho-specific antibodies, the PVDF membranes were immediately stripped by placing the membrane in stripping buffer (0.5 M NaCl and 0.5 M acetic acid) for 10 min at room temperature. The membrane was then washed once for 10 min in TBS-Tween, reblocked, and blotted with antibodies to the unphosphorylated form of the enzyme to control for equal protein loading.
Ras-GTP Pull-Down Assay
LßT2 cells were plated in 10-cm dishes and grown until confluence. Cells were serum starved overnight and then stimulated with GnRH (100 nM), PMA (100 nM), PDGF (20 ng/ml), or KCl (50 mM) for 5 min at 37 C. Cells were washed with ice-cold PBS, lysed in RIPA buffer (25 mM HEPES, pH 7.5, 150 mM NaCl, 1% NP-40, 0.25% sodium deoxycholate, 10% glycerol, 25 mM NaF, 10 mM MgCl2, 1 mM EDTA, 1 mM sodium orthovanadate, 10 µg/ml leupeptin, 10 µg/ml aprotinin) and clarified by centrifugation. A GST-fusion protein (10 µg) containing the ras-binding domain of Raf was added and incubated on ice for 60 min. This fusion protein binds the active GTP-bound form of ras. The fusion protein was precipitated on glutathione Sepharose beads and washed three times in binding buffer. The pellets were boiled in SDS-sample buffer, and the proteins were separated on 12% SDS polyacrylamide gels, transferred to PVDF membranes, and immunoblotted with a pan-ras antibody as above.
Isolation of Nuclear and Cytoplasmic Fractions
LßT2 cells were plated in 10-cm dishes and grown until confluence. Cells were serum starved overnight, then pretreated with vehicle or 1 µM BIM-1 for 30 min, and then stimulated with 100 nM GnRH for 5 min at 37 C. Cells were washed with cold PBS and harvested, and nuclei were prepared according to a published procedure (65). Briefly, cells were resuspended in nuclear isolation buffer [10 mM Tris-HCl (pH 7.8), 1% NP-40, 10 mM mercaptoethanol, 0.5 mM phenylmethylsulfonylfluoride, 1 µg/ml aprotinin, 1 µg/ml leupeptin, 10 µg/ml soybean trypsin inhibitor, 15 µg/ml calpain inhibitor 1 and 2, 2 mM Na3VO4, and 5 mM NaF] for 3 min on ice. An equal volume of water was added, and the cells were allowed to swell for 3 min. The cells were sheared by eight passages through a 22-gauge needle. Nuclei were recovered by centrifugation at 400 x g at 4 C for 6 min and then washed once in 10 mM Tris-HCl (pH 7.8), 2 mM MgCl2 plus protease and phosphatase inhibitors as before. The supernatant was used as the cytoplasmic fraction. The nuclei were solubilized in 25 mM HEPES (pH 7.5), 10 mM MgCl2, 5 mM EDTA, 5 mM EGTA, 50 mM NaCl, 50 mM NaF, 30 mM sodium pyrophosphate, 10% glycerol, 1% Triton X-100 plus protease inhibitors as above for 20 min at 4 C with shaking. Cell debris was removed by centrifugation at 12,000 x g at 4 C for 5 min, and the supernatant was used as the nuclear fraction. Aliquots of nuclear and cytoplasmic fractions containing equal amounts of protein were resolved by SDS-PAGE, transferred to PVDF membranes, and immunoblotted with the Anti-ACTIVE ERK antibodies as before.
 |
FOOTNOTES
|
---|
This work was supported by a U54 Center Grant, HD-12303, from the NIH.
Abbreviations: BAPTA-AM, 1,2-bis(2-Aminophenoxy)ethane- N,N,N',N'-tetraacetic acid acetoxymethyl ester; BIM-1, bisindolylmaleimide; DAG, diacylglycerol; GPCR, G protein-coupled receptor; GST, glutathione-S-transferase; JNK, c-Jun N-terminal kinase; MEK, MAPK kinase; MKK, dual-specificity kinase; PDGF, platelet-derived growth factor; PMA, phorbol-12-myristate-13-acetate; PVDF, polyvinylidene difluoride; TBS, Tris-buffered saline; TRITC, tetramethylrhodamine isothiocyanate.
Received for publication July 13, 2001.
Accepted for publication November 27, 2001.
 |
REFERENCES
|
---|
-
Pierce JG, Parsons TF 1981 Glycoprotein hormones: structure, function. Annu Rev Biochem 50:465495[CrossRef][Medline]
-
Kaiser UB, Conn PM, Chin WW 1997 Studies of gonadotropin-releasing hormone (GnRH) action using GnRH receptor-expressing pituitary cell lines. Endocr Rev 18:4670[Abstract/Free Full Text]
-
Mellon PL, Windle JJ, Weiner RI 1991 Immortalization of neuroendocrine cells by targeted oncogenesis. Recent Prog Horm Res 47:6996[Medline]
-
Alarid ET, Windle JJ, Whyte DB, Mellon PL 1996 Immortalization of pituitary cells at discrete stages of development by directed oncogenesis in transgenic mice. Development 122:33193329[Abstract/Free Full Text]
-
Alarid ET, Holley S, Hayakawa M, Mellon PL 1998 Discrete stages of anterior pituitary differentiation recapitulated in immortalized cell lines. Mol Cell Endocrinol 140:2530[CrossRef][Medline]
-
Sosnowski R, Mellon PL, Lawson MA 2000 Activation of translation in pituitary gonadotrope cells by gonadotropin-releasing hormone. Mol Endocrinol 14:18111819[Abstract/Free Full Text]
-
Thomas P, Mellon PL, Turgeon J, Waring DW 1996 The L ß T2 clonal gonadotrope: a model for single cell studies of endocrine cell secretion. Endocrinology 137:29792989[Abstract]
-
Turgeon JL, Kimura Y, Waring DW, Mellon PL 1996 Steroid and pulsatile gonadotropin-releasing hormone (GnRH) regulation of luteinizing hormone and GnRH receptor in a novel gonadotrope cell line. Mol Endocrinol 10:439450[Abstract]
-
Gharib SD, Wierman ME, Shupnik MA, Chin WW 1990 Mitogen signaling via G protein-coupled receptor. Endocr Rev 1:177199
-
Naor Z, Benard O, Seger R 2000 Activation of MAPK cascades by G-protein-coupled receptors: the case of gonadotropin-releasing hormone receptor. Trends Endocrinol Metab 11:9199[CrossRef][Medline]
-
Van Biesen T, Luttrel LM, Hawes BE, Lefkowitz RJ 1996 Mitogenic signaling via G protein-coupled receptor. Endocr Rev 17:698671[Medline]
-
Gutkind JS 1998 The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J Biol Chem 273:18391842[Free Full Text]
-
Campbell JS, Seger R, Graves LM, Jensen AM, Krebs EG 1995 The MAPK kinase cascade. Recent Prog Horm Res 50:131159[Medline]
-
Widmann C, Gibson S, Jarpe MB, Johnson GL 1999 Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 79:143180[Abstract/Free Full Text]
-
Denhardt DT 1996 Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signaling. Biochem J 318:729747[Medline]
-
Cohen P 1997 The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends Cell Biol 7:353361[CrossRef]
-
Whitmarsh AJ, Davis RJ 1996 Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 74:589607[CrossRef][Medline]
-
Canagarajah BJ, Khokhlatchev A, Cobb MH, Goldsmith EJ 1997 Activation mechanism of the MAP Kinase ERK2 by dual phosphorylation. Cell 90:859869[Medline]
-
Derijard B, Raingeaud J, Barrett T, Wu IH, Han J, Ulevitch RJ, Davis RJ 1995 Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267:682685[Medline]
-
Sanchez I, Hughes RT, Mayer BJ, Yee K, Woodgett JR, Avruch J, Kyriakis JM, Zon LI 1994 Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature 372:794798[Medline]
-
Han J, Wang X, Jiang Y, Ulevitch RJ, Lin S 1997 Identification and characterization of a predominant isoform of human MKK3. FEBS Lett 403:1922[CrossRef][Medline]
-
Han J, Lee JD, Jiang Y, Li Z, Feng L, Ulevitch RJ 1996 Characterization of the structure and function of a novel MAP kinase kinase (MKK6). J Biol Chem 271:28862891[Abstract/Free Full Text]
-
Foltz IN, Gerl RE, Wieler JS, Luckach M, Salmon RA, Schrader JW 1998 Human mitogen-activated protein kinase kinase 7 (MKK7) is a highly conserved c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) activated by environmental stresses and physiological stimuli. J Biol Chem 273:93449351[Abstract/Free Full Text]
-
Mitchell R, Sim PJ, Leslie T, Johnson MS, Thomason FJ 1994 Activation of MAP kinases associated with the priming effect of LHRH. J Endocrinol 140:R15R18
-
Haisenleder DJ, Cox ME, Parsons SJ, Marshall JC 1998 Gonadotropin-releasing hormone pulses are required to maintain activation of mitogen-activated protein kinase: role in stimulation of gonadotrope gene expression. Endocrinology 139:31043111[Abstract/Free Full Text]
-
Sim PJ, Wolbers WB, Mitchell R 1995 Activation of MAP kinase by the LHRH receptor through a dual mechanism involving protein kinase C and a pertussis toxin-sensitive G protein. Mol Cell Endocrinol 112:257263[CrossRef][Medline]
-
Sim P, Mitchell R 1995 Activation of MAP kinase by the LHRH receptor through a PKC-dependent pertussis toxin-sensitive mechanism. Biochem Soc Trans 23:144S (Abstract)
-
Johnson MS, Lutz EM, MacKenzie CJ, Wolbers WB, Robertson DN, Holland PJ, Mitchell R 2000 Gonadotropin-releasing hormone receptor activation of extracellular signal-regulated kinase and tyrosine kinases in transfected GH3 cells and in
T31 cells. Endocrinology 141:30873097[Abstract/Free Full Text]
-
Roberson MS, Misra-Press A, Laurence ME, Stork PJS, Maurer RA 1995 A role for mitogen-activated protein kinase in mediating activation of the glycoprotein hormone
-subunit promoter. Mol Cell Biol 15:35313539[Abstract]
-
Sundaresan S, Colin IM, Pestell RG, Jameson JL 1996 Stimulation of mitogen-activated protein kinase by gonadotropin releasing hormone: evidence for the involvement of protein kinase C. Endocrinology 137:304311[Abstract]
-
Reiss N, Llevi LN, Shacham S, Harris D, Seger R, Naor Z 1997 Mechanism of mitogen-activated protein kinase activation by gonadotropin-releasing hormone in the pituitary of
T31 cell line: differential roles of calcium and protein kinase C. Endocrinology 138:16731682[Abstract/Free Full Text]
-
Mulvaney JM, Roberson MS 2000 Divergent signaling pathways requiring discrete calcium signals mediate concurrent activation of two mitogen-activated protein kinases by gonadotropin-releasing hormone. J Biol Chem 275:1418214189[Abstract/Free Full Text]
-
Mulvaney JM, Zhang T, Fewtrell C, Roberson MS 1999 Calcium influx through L-type channels is required for selective activation of extracellular signal-regulated kinase by gonadotropin-releasing hormone. J Biol Chem 274:2979629804[Abstract/Free Full Text]
-
Levi NL, Hanoch T, Benard O, Rozenblat M, Harris D, Reiss N, Naor Z, Seger R 1998 Stimulation of Jun N-terminal kinase (JNK) by gonadotropin-releasing hormone in the pituitary
T31 cell line is mediated by protein kinase C, c-Src, and CDC42. Mol Endocrinol 12:815824[Abstract/Free Full Text]
-
Roberson MS, Zhang T, Li HL, Mulvaney JM 1999 Activation of the p38 mitogen-activated protein kinase pathway by gonadotropin-releasing hormone. Endocrinology 140:13101318[Abstract/Free Full Text]
-
Yokoi T, Ohmichi M, Tasaka K, Kimura A, Kanda Y, Hayakawa J, Tahara M, Hisamoto K, Kurachi H, Murata Y 2000 Activation of the luteinizing hormone ß promotor by gonadotropin-releasing hormone requires c-Jun NH2-terminal protein kinase. J Biol Chem 275:2163921647[Abstract/Free Full Text]
-
Khokhlatchev AV, Canagarajah B, Wislbacher J, Robinson M, Atkinson M, Goldsmith EJ, Cobb MH 1998 Phosphorylation of the MAP Kinase ERK2 promotes its homodimerization and nuclear translocation. Cell 93:605615[Medline]
-
Abbas M, Evans JJ 1999 Regulation of c-fos protein in gonadotrope cells by oxytocin and gonadotropin-releasing hormone. Neuroendocrinology 71:292300[CrossRef]
-
Cesnjaj M, Cat KJ, Stojikovic SS 1994 Co-ordinate actions of calcium and protein kinase-C in the expression of primary response genes in pituitary gonadotrophs. Endocrinology 135:692701[Abstract]
-
Tremblay JJ, Drouin J 1999 Egr-1 is a downstream effector of GnRH and synergizes by direct interaction with Ptx1 and SF-1 to enhance luteinizing hormone ß gene transcription. Mol Cell Biol 19:25672576[Abstract/Free Full Text]
-
Halvorson LM, Kaiser UB, Chin WW 1999 The protein kinase C system acts through the early growth response protein 1 to increase LHß gene expression in synergy with steroidogenic factor-1. Mol Endocrinol 13:106116[Abstract/Free Full Text]
-
Ben-Menahem D, Shraga-Levine Z, Mellon PL, Naor Z 1995 Mechanism of action of gonadotropin-releasing hormone upon gonadotropin
-subunit mRNA levels in the
T31 cell line: role of Ca2+ and protein kinase C. Biochem J 309:325329[Medline]
-
Ben-Menahem D, Naor Z 1994 Regulation of gonadotropin mRNA levels in cultured rat pituitary cells by gonadotropin-releasing hormone (GnRH): role for Ca2+ and protein kinase C. Biochemistry 33:36983704[Medline]
-
Weck J, Fallest PC, Pitt LK, Shupnik MA 1998 Differential gonadotropin-releasing hormone stimulation of rat luteinizing hormone subunit gene transcription by Ca2+ influx and mitogen-activated protein kinase-signaling pathways. Mol Endocrinol 12:451457[Abstract/Free Full Text]
-
Saunders BD, Sabbagh E, Chin WW, Kaiser UB 1998 Differential use of signal transduction pathways in the gonadotropin-releasing hormone-mediated regulation of gonadotropin subunit gene expression. Endocrinology 139:18351843[Abstract/Free Full Text]
-
Kolch W, Heidecker G, Hochs G, Hummel R, Vahidi H, Mischak H, Finkenzeller, G, Marme D, Rapp UR 1993 Protein kinase C activates Raf-1 by direct phosphorylation. Nature 364:249252[CrossRef][Medline]
-
Diaz B, Barnard D, Filson A, NacDonald S, King A, Marshall M 1997 Phosphorylation of Raf-1 Serine 338-Serine 339 is an essential regulatory event for ras-dependent activation and biological signaling. Mol Cell Biol 17:45094516[Abstract]
-
Mason CS, Springer CJ, Cooper RG, Superti-Furga, G, Marshall CJ, Marais R 1999 serine and tyrosine phosphorylations cooperate in Raf-1 but not B-Raf activation. EMBO J 18:21372148[Abstract/Free Full Text]
-
Benard O, Naor Z, Seger R 2000 Role of dynamin, Src and Ras in the PKC-mediated activation of ERK by gonadotropin-releasing hormone. J Biol Chem 276:45544563[Abstract/Free Full Text]
-
Grosse R, Roelle S, Herrlich A, Hohn J, Gudermann T 2000 Epidermal growth factor receptor tyrosine kinase mediates Ras activation by gonadotropin-releasing hormone. J Biol Chem 275:1225112260[Abstract/Free Full Text]
-
Ueda Y, Hirai S, Osada S, Suzuki A, Mizuno K, Ohno S 1996 Protein Kinase C
activates the MEK-ERK pathway in a manner independent of ras and dependent on Raf. J Biol Chem 271:2351223519[Abstract/Free Full Text]
-
Hamilton M, Liao J, Cathcart MK, Wolfman A 2001 Constitutive association of c-N-ras with c-Raf-1 and Protein kinase C
in latent signaling molecules. J Biol Chem 276:2907929090[Abstract/Free Full Text]
-
Corbit KC, Soh JW, Yoshida K, Eves EM, Weinstein IB, Rosner MR 2000 Different protein kinase C isoforms determine growth factor specificity in neuronal cells. Mol Cell Biol 20:53925403[Abstract/Free Full Text]
-
Marais R, Light Y, Mason C, Paterson H, Olson MF, Marshall CJ 1998 Requirement of Ras-GTP-Raf complexes for activation of Raf-1 by protein kinase C. Science 280:109112[Abstract/Free Full Text]
-
Chaudhary A, King WG, Mattaliano MD, Frost JA, Diaz B, Morrison DK, Cobb MH, Marshall MS, Brugge JS 2000 Phosphatidylinositol 3-kinase regulates Raf1 through Pak phosphorylation of Ser338. Curr Biol 10:551554[CrossRef][Medline]
-
Sun H, King AJ, Diaz HB, Marshall MS 2000 Regulation of the protein kinase Raf-1 by oncogenic ras through phosphatidylinositol 3-kinase, Cdc42/Rac and Pak. Curr Biol 10:281284[CrossRef][Medline]
-
Egea J, Espinet C, Comella JX 1999 Calcium influx activates extracellular-regulated kinase/mitogen-activated protein kinase pathway through a calmodulin-sensitive mechanism in PC12 cells. J Biol Chem 274:7585[Abstract/Free Full Text]
-
Adachi M, Fukuda M, Nishida E 1999 Two co-existing mechanisms for nuclear import of MAP kinase: passive diffusion of a monomer and active transport of a dimer. EMBO J 18:53745378
-
Luttrell LM, Roudabush FL, Choy EW, Miller WE, Field ME, Pierce KL, Lefkowitz RJ 2001 Activation and targeting of extracellular signal-regulated kinases by ß-arrestin scaffolds. Proc Natl Acad Sci USA 98:24492454[Abstract/Free Full Text]
-
Karandikar M, Xu S, Cobb MH 2000 MEKK1 binds raf-1 and the ERK2 cascade components. J Biol Chem 275:4012040127[Abstract/Free Full Text]
-
Yasuda J, Whitmarsh AJ, Cavanagh J, Sharma M, Davis RJ 1999 The JIP group of mitogen-activated protein kinase scaffold proteins. Mol Cell Biol 19:72457254[Abstract/Free Full Text]
-
Burger LL, Dalkin AC, Aylor KW, Workman LJ, Haisenleder DJ, Marshall JC 2001 Regulation of gonadotropin subunit transcription after ovariectomy in the rat: measurement of subunit primary transcript reveals differential roles of GnRH and inhibin. Endocrinology 142:34252442
-
Pernasetti F, Vasilyev VV, Rosenberg SB, Bailey JS, Huang HJ, Miller WL, Mellon PL 2001 Cell-specific transcriptional regulation of follicle-stimulating hormone-ß by activin and gonadotropin-releasing hormone in the LßT2 pituitary gonadotrope cell model. Endocrinology 142:22842295[Abstract/Free Full Text]
-
Ji Q, Carpenter G 2000 Role of basal calcium in the EGF activation of MAP kinases. Oncogene 19:18531856[CrossRef][Medline]
-
Hill CS, Treisman R 1995 Differential activation of c-fos promoter elements by serum, lysophosphatidic acid, G proteins and polypeptide growth factors. EMBO J 14:50375047[Abstract]